The Technologies in I.B.M.’s Watson Used for Drug Research – NYTimes.com
“I.B.M.’s Strategic Intellectual Property Insight Platform. Clearly, the Watson branding team didn’t work on this name.
But then again, this isn’t for television, where Watson performed. It is for major corporate customers, seeking competitive advantage. The technology, sold as a cloud-based service, is the result of several years of joint development between IBM Research and four companies — AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer.
The insight platform uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.”
Gapingvoid: Flowers vs Elephants
So true… Click to see cartoon
Bre Pettis | I Make Things – Bre Pettis Blog – The Cult of Done Manifesto
Good one—> “#13 Done is the engine of more.”
Monitor: More than just digital quilting | The Economist
“The maker movement is both a response to and an outgrowth of digital culture, made possible by the convergence of several trends. New tools and electronic components let people integrate the physical and digital worlds simply and cheaply. Online services and design software make it easy to develop and share digital blueprints. And many people who spend all day manipulating bits on computer screens are rediscovering the pleasure of making physical objects and interacting with other enthusiasts in person, rather than online. Currently the preserve of hobbyists, the maker movement’s impact may be felt much farther afield.”